(ii) any bond, note, debenture, loan stock or othersimilar instrument;
(iv) receivables sold or discounted (other than any receivables sold on a non-recourse basis) and any Qualified Receivables Financing;
(v) any sale and lease-back transaction, or similar transaction which is treated as indebtedness under IFRS;
(vi) any liability under a deferred purchase agreement where the deferred payment is arranged primarily as a method of raising finance or financing the acquisition of that asset;
(vii) any Swap Agreement or any other derivative transaction entered into in connection with protection against or benefit from fluctuation in any rate or price, including without limitation currency or interest rate swaps, caps or collar transactions (and,
11/96
when calculating the value of the transaction, only the marked-to-market value shall be taken into account);
(viii) any amounts raised under any other transactions having the commercial effect of a borrowing or raising of money, (including any forward sale or purchase agreement);
(ix) any counter-indemnity obligation in respect of a guarantee, indemnity, bond, standby or documentary letter of credit or any other instrument issued by a bank or financial institution in respect of any underlying liability; and
